U.S. Diversified Financial Stock News

Shares of U.S. Physical Therapy (USPH) have struggled over the past month, falling 16%. The stock is down 17% for the past year. However, underlying revenue and net income have continued to post positive annual growth, which might catch investors’ attention. See our latest analysis for U.S. Physical Therapy. After tumbling more than 15% in the past month, U.S. Physical Therapy's share price is clearly losing momentum, even as the company posts steady revenue and net income gains. Over the...

Microchip Technology Incorporated ( NASDAQ:MCHP ) will pay a dividend of $0.455 on the 9th of December. This means the...

Despite posting some strong earnings, the market for Sterling Infrastructure, Inc.'s ( NASDAQ:STRL ) stock hasn't moved...

Clarivate (CLVT) just posted third quarter results, narrowing its net loss and showing sales growth compared to last year. The company also raised its full-year revenue outlook, which is encouraging for investors tracking its turnaround. See our latest analysis for Clarivate. After a tough start to the year, Clarivate’s share price has regained some momentum, rising nearly 3% in the past week after management delivered better-than-expected third quarter earnings and lifted their full-year...

Raytheon recently announced it signed a Memorandum of Understanding with Avio to help establish a solid rocket motor facility in the United States, which will serve Raytheon and other customers as a vertically integrated merchant supplier with preferred access for Raytheon. This collaboration is expected to bolster domestic manufacturing capabilities for advanced defense components and strengthen both companies' supply chain resilience to meet growing global defense demand. We'll explore how...

Recently, Schrödinger reported third quarter results showcasing robust year-over-year revenue growth driven by both software and drug discovery segments, alongside revised 2025 guidance and a narrowed quarterly net loss. Copernic Catalysts, in collaboration with Schrödinger, announced surpassing a major technical milestone for the Neptune ammonia catalyst, highlighting significant potential industrial and environmental benefits. We'll explore how this advancement in ammonia catalyst...

Ionis Pharmaceuticals (IONS) shares have seen positive momentum lately, catching the eye of investors seeking growth in biotech. With strong annual revenue and net income trends, the company is drawing attention as industry dynamics continue to evolve. See our latest analysis for Ionis Pharmaceuticals. Ionis Pharmaceuticals’ share price has surged 108.85% year-to-date, fueled by promising pipeline developments and renewed optimism around biotech innovation. Long-term total shareholder returns...

United States Lime & Minerals just released its third quarter earnings, showing steady growth in both sales and net income compared to last year. The company also announced its regular quarterly dividend, highlighting consistent shareholder returns. See our latest analysis for United States Lime & Minerals. United States Lime & Minerals has seen some bounce in its share price lately, with a 7.3% climb over the past week hinting at renewed momentum following its strong quarterly results and...

Fortune Brands Innovations (FBIN) just posted its third quarter results, showing a noticeable drop in net income and earnings per share compared to last year. Sales edged down slightly as well. The company’s full-year guidance remains unchanged. See our latest analysis for Fortune Brands Innovations. After a weak quarter and little growth projected ahead, Fortune Brands Innovations’ stock has seen momentum fade. The 1-year total shareholder return is -34.95% and the year-to-date share price...

GeneDx Holdings is in the spotlight as it prepares to reveal new research at the upcoming National Society of Genetic Counselors Annual Meeting. The company’s presentations focus on cutting-edge genomic data and advancements in rare disease diagnosis, highlighting their leadership in precision medicine. See our latest analysis for GeneDx Holdings. After news of GeneDx’s landmark research presentations and growing recognition at major industry events, momentum appears to be building. The...

D-Wave Quantum (NYSE:QBTS) has captured attention recently after reporting 100% year-over-year revenue growth, along with new customer wins and public sector collaborations. The company’s technology is being implemented both commercially and within U.S. government projects. See our latest analysis for D-Wave Quantum. The recent surge in real-world wins, such as D-Wave’s collaboration with BASF and the U.S. government, has only amplified interest around its technology. That excitement is...

Hut 8 Corp. recently reported third-quarter 2025 earnings, revealing a sharp year-over-year rise in revenue to US$83.51 million and a significant increase in net income to US$50.11 million. Ongoing development at the Corpus Christi and River Bend sites has attracted interest from AI and cloud firms, reflecting Hut 8's expanding role beyond Bitcoin mining. We'll explore how Hut 8's robust earnings growth and progress at key infrastructure sites shape its outlook within the current investment...

American Airlines CEO Robert Isom recently confirmed that, amid the longest U.S. government shutdown to date, the airline canceled more than 220 scheduled flights due to worsening air traffic controller shortages and incremental FAA-mandated traffic reductions of up to 10% by November 14. The disruption highlights how extended government shutdowns can compound operational risks for airlines by deepening staff shortages and forcing major service reductions. We'll explore how these government...

In the past week, Apple announced the integration of Google Gemini AI into Siri beginning in spring 2026, alongside strong quarterly results showing revenue of US$102.47 billion and net income of US$27.47 billion for the fourth quarter ended September 27, 2025. This partnership marks a significant step for Apple, potentially ushering in a new era of AI-enabled features that could enhance device sales and user engagement. We'll examine how the upcoming Google AI integration within Siri...

In the past week, Stephens initiated coverage on Signet Jewelers with an Overweight rating, highlighting a strengthened business position and early progress under new leadership. Their report marks a reversal in sentiment, noting that lab-grown diamonds, once considered a challenge, are now seen as a key advantage for Signet's business model. The endorsement also underscored Signet’s ability to generate consistent and meaningful free cash flow despite macroeconomic uncertainties, indicating...

Howard Hughes Holdings announced strong third-quarter results, reporting revenue of US$390.24 million and diluted earnings per share of US$2.02, both above analyst expectations and consensus estimates. The company achieved record land and condominium pre-sales, revised its full-year financial guidance upward, and emphasized a significant liquidity position to support ongoing development and reinvestment initiatives. We’ll examine how the surge in condominium pre-sales and revised guidance...

On November 11, 2025, Agree Realty Corporation declared a new monthly cash dividend of US$0.262 per common share and a monthly preferred dividend of US$0.08854 per depositary share, both payable in December to shareholders of record in late November. This 3.6% increase in the annualized common dividend signals management's confidence in the stability of Agree Realty's core business and its ability to generate consistent rental income. Next, we'll examine how Agree Realty's dividend increase...

As the Dow Jones Industrial Average reaches new heights amid optimism surrounding a potential end to the U.S. government shutdown, investors are closely watching market fluctuations with mixed performances across major indices. In this environment, identifying stocks that may be undervalued becomes crucial, as these investments could offer opportunities for growth when priced below their intrinsic value.

As the Dow Jones Industrial Average reaches an all-time high amid optimism over a potential end to the U.S. government shutdown, investors are keenly observing market movements and seeking opportunities in promising growth sectors. In this environment, stocks with significant insider ownership can be particularly appealing, as they often indicate confidence from those closest to the company’s operations and strategy.

As the Dow Jones Industrial Average reaches an all-time high amid optimism over the potential end of a prolonged U.S. government shutdown, investors are keenly observing market dynamics and seeking opportunities across various sectors. Penny stocks, often seen as a gateway to investing in smaller or emerging companies, continue to hold allure for those looking for growth at accessible price points. Despite their historical reputation for volatility, penny stocks with strong financials and...

Just because a business does not make any money, does not mean that the stock will go down. For example, Insight...

Tanger Inc. reported third-quarter 2025 results showing increased revenue to US$145.21 million and net income of US$32.03 million, and also raised its full-year diluted earnings outlook. The earnings announcement highlighted ongoing year-over-year growth for the company, despite some analyst caution and recent insider share sales. To understand what this means for Tanger, we'll examine how the strong quarterly earnings growth could impact the company's investment narrative. We've found 15 US...

Elevance Health (ELV) has drawn increased attention after recently reaffirming its 2025 earnings guidance and benefit expense ratio ahead of a series of investor meetings. The company’s focus on proactive engagement signals confidence to the market. See our latest analysis for Elevance Health. Elevance Health has made headlines with its proactive communication, but the market response has been anything but steady. The latest share price rally of 3.8% in a single day only partially offsets...

Collegium Pharmaceutical (COLL) stock has moved in line with recent sector activity and is drawing investor attention amid shifting trends in the pharmaceutical space. The company's performance this month has outpaced broader indexes and has sparked renewed interest in the underlying value story. See our latest analysis for Collegium Pharmaceutical. Collegium Pharmaceutical’s 1-month share price return of nearly 40% has turned heads, and momentum is visibly building after a standout year,...